Staphylococcal peptidoglycan suppresses production of interleukin-2 by T cells through a T cell-derived factor induced by direct contact between T cells and monocytes

被引:10
|
作者
Nakagawa, Y [1 ]
Murai, T [1 ]
机构
[1] Soc Japanese Pharmacopoeia, Osaka Branch, Chuo Ku, Osaka 5410046, Japan
来源
JOURNAL OF INFECTIOUS DISEASES | 2003年 / 188卷 / 09期
关键词
TOLL-LIKE RECEPTORS; NECROSIS-FACTOR-ALPHA; GROWTH-FACTOR-BETA; DIFFERENTIAL EXPRESSION; LIPOTEICHOIC ACID; INDUCTION; SEPSIS; LYMPHOCYTES; APOPTOSIS; RESPONSES;
D O I
10.1086/379036
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
During the last 2 decades, the incidence of sepsis due to gram-positive bacteria has increased dramatically. Nevertheless, effects of the cell-wall components that do not contain endotoxin, on immunity, are still largely unknown. Here, we demonstrate, for the first time, that the gram-positive bacterial cell-wall component peptidoglycan (PGN) severely inhibits the production of interleukin (IL)-2 by cultured human peripheral blood mononuclear cells stimulated with anti-CD3 and anti-CD28 antibodies. Furthermore, we provide evidence that the inhibitory effect is mediated predominantly by a soluble mediator produced by T cells and that the production of the inhibitory mediator is induced by direct cell-to-cell contact of T cells with PGN-stimulated monocytes. The T cell-derived inhibitory mediator is distinct from known immunosuppressive lymphokines, such as IL-10 and IL-4. In light of the key role of IL-2 in cell-mediated immunity, it can be suggested that PGN induces the dysfunction of cell-mediated immunity.
引用
收藏
页码:1284 / 1294
页数:11
相关论文
共 50 条
  • [31] HUMAN INTERLEUKIN-2 - PRODUCTION BY BOTH TG-CELLS AND OTHER T-CELLS
    SILVA, AG
    ALVAREZ, JM
    BONNARD, GD
    DELANDAZURI, MO
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1981, 14 (03) : 315 - 320
  • [32] COLONY FORMATION AND INTERLEUKIN-2 PRODUCTION BY LEUKEMIC HUMAN T-CELLS
    KRAJEWSKI, AS
    DEWAR, AE
    SEIDELIN, PH
    MURRAY, R
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1983, 54 (01): : 103 - 109
  • [33] INHIBITION OF INTERLEUKIN-2 SYNTHESIS AND INTERLEUKIN-2 RECEPTOR-ALPHA EXPRESSION ON T-CELLS BY A CELL-FREE FACTOR DERIVED FROM A CD4+ REGULATORY T-CELL CLONE
    OKINO, T
    CHAKRABORTY, NG
    STABACH, P
    TWARDZIK, DR
    PADULA, SJ
    MUKHERJI, B
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1993, 68 (03): : 256 - 262
  • [34] SEZARY T-CELL-ACTIVATING FACTOR INDUCES FUNCTIONAL INTERLEUKIN-2 RECEPTORS ON T-CELLS DERIVED FROM PATIENTS WITH SEZARY-SYNDROME
    ABRAMS, JT
    GHOSH, SK
    DEFREITAS, E
    CANCER RESEARCH, 1993, 53 (22) : 5501 - 5506
  • [35] Low dose interleukin-2 therapy for ischemic retinopathies: correcting the balance between regulatory T cells and effector T cells
    Deliyanti, Devy
    Yanfaunnas, Faisal Farras
    Joglekar, Amit
    Wilkinson-Berka, Jennifer L.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [36] INTERLEUKIN-2 PRODUCTION BY ALLOANTIGEN (H-2) ACTIVATED T-CELLS
    ANDRUS, L
    LAFFERTY, KJ
    AUSTRALIAN JOURNAL OF EXPERIMENTAL BIOLOGY AND MEDICAL SCIENCE, 1981, 59 (AUG): : 413 - 426
  • [37] T-CELL GROWTH-FACTOR (INTERLEUKIN-2)
    ALTMAN, A
    IMMUNOLOGY TODAY, 1981, 2 (01): : 1 - 3
  • [38] Neoantigen Specific T Cells Derived From T Cell-Derived Induced Pluripotent Stem Cells for the Treatment of Hepatocellular Carcinoma: Potential and Challenges
    Lu, Fei
    Ma, Xiao-Jing-Nan
    Jin, Wei-Lin
    Luo, Yang
    Li, Xun
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [39] High Frequency Production of T Cell-Derived iPSC Clones Capable of Generating Potent Cytotoxic T Cells
    Nagano, Seiji
    Maeda, Takuya
    Ichise, Hiroshi
    Kashima, Soki
    Ohtaka, Manami
    Nakanishi, Mahito
    Kitawaki, Toshio
    Kadowaki, Norimitsu
    Takaori-Kondo, Akifumi
    Masuda, Kyoko
    Kawamoto, Hiroshi
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2020, 16 : 126 - 135
  • [40] INTERLEUKIN-2 INDUCES T-CELL-DEPENDENT IGM PRODUCTION IN HUMAN B-CELLS
    SAUERWEIN, RW
    VANDERMEER, WGJ
    DRAGER, A
    AARDEN, LA
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1985, 15 (06) : 611 - 616